Disoproxil FumarateExport to Nigeria

Nigeria should be considered a major country for hepatitis elimination efforts due to its huge population and relatively high prevalence of hepatitis B and C. Nigeria’s population was expected to be over 190 million in 2017, and it is fast increasing, with forecasts indicating that by 2050, it would surpass the United States to become the world’s third most populated country.

Challenges faced by Nigeria
Despite the development of standards and strategic direction to lead Nigeria’s response to viral hepatitis, significant obstacles remain that must be overcome in order to meet elimination targets. These include geographical and financial barriers to testing and treatment, and also the availability of substitute tests and treatment providers that are unconnected to the health system and ineffective in terms of treatment outcomes.
In Nigeria, health-care resources, especially the health-care workforce, are disproportionately allocated to Third party Tenofovir Disoproxil Fumarate (tenoheal) manufacturer to Nigeria, which are primarily located in urban regions. The majority of hepatitis treatment in Nigeria is now offered at higher level clinics, which are out of reach for the majority of the population.

Increasing access to health care in Nigeria for better treatment of HIV/aids
In Nigeria, vertical health programs have aided in addressing some of the public health challenges. However, unless vertical health programs are integrated into the national health plan, they expose the success of PHC implementation. Because disease-specific health interventions place an enormous burden on weak health systems in comprehensive PHC is preferred over selective PHC and export freely to Nigeria from India.

Expanding poor and vulnerable populations’ access to high-quality health care necessitates
The use of community-based health workers (CHWs) to increase; the equitable distribution of health workers; the building of a cadre of primary care and family physicians; the establishment of PHC as a national priority; and the pursuit of PHC focused on UHC.

Introducing medication like Tenofovir Disoproxil Fumarate 300mg in Nigeria
Some of the Bulk exporter of Tenofovir Disoproxil Fumarate (tenoheal) to Nigeria are helping the country by providing better medication at reasonable rate to help the masses get the best treatment within a period. Among the leading companies which are into delivering best treatment to HIV/Aids in Nigeria, Healing Pharma is exporter of Bulk pharma products to Nigeria. The company is a wholesale pharmaceutical exporter to Nigeria which offers Tenofovir a medication that is used in combination with other HIV drugs to help control the infection.

How to consume Tenofovir Disoproxil Fumarate 300mg for HIV/aids?

Take Tenofovir Disoproxil Fumarate 300mg once a day, with food, as instructed by your doctor.

Your dosage is determined by your health condition, fluid balance, and therapy response.

It is critical that you continue to take this (and other HIV drugs) exactly as your doctor prescribes. Make sure you don’t miss any doses.

Such approaches will help Nigeria’s expanding illness burden and health-care expenses. With a focus on PHC, countries including and India have been able to develop their health systems. This has been accomplished through significant investment in primary health care and the development of policy innovations that have resulted in improved population health outcomes at reduced costs and a decrease in health disparities.
In the end, it is very important to stay healthy and keep the basic protocols in mind when you suffer with HIV. Be it any country, one’s healthy lifestyle and its maintenance is very important. There are definitely many health care programs that a patient in Nigeria may consider confirming and take advantage of to get himself/ herself treated time to time.